GB0807216D0 - Drug combination for the treatment of duchenne muscular dystrophy - Google Patents

Drug combination for the treatment of duchenne muscular dystrophy

Info

Publication number
GB0807216D0
GB0807216D0 GB0807216A GB0807216A GB0807216D0 GB 0807216 D0 GB0807216 D0 GB 0807216D0 GB 0807216 A GB0807216 A GB 0807216A GB 0807216 A GB0807216 A GB 0807216A GB 0807216 D0 GB0807216 D0 GB 0807216D0
Authority
GB
United Kingdom
Prior art keywords
treatment
muscular dystrophy
drug combination
duchenne muscular
duchenne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0807216A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GB0807216A priority Critical patent/GB0807216D0/en
Publication of GB0807216D0 publication Critical patent/GB0807216D0/en
Priority to PL08788620T priority patent/PL2170396T3/en
Priority to US12/600,242 priority patent/US8501713B2/en
Priority to TW097129385A priority patent/TW200911237A/en
Priority to PE2008001295A priority patent/PE20090510A1/en
Priority to PCT/GB2008/050648 priority patent/WO2009019504A1/en
Priority to RS20170207A priority patent/RS55735B1/en
Priority to EP16203981.2A priority patent/EP3251694A1/en
Priority to EP08788620.6A priority patent/EP2170396B1/en
Priority to LTEP08788620.6T priority patent/LT2170396T/en
Priority to DK08788620.6T priority patent/DK2170396T3/en
Priority to ES08788620.6T priority patent/ES2617957T3/en
Priority to PT87886206T priority patent/PT2170396T/en
Priority to BRPI0811317-3A2A priority patent/BRPI0811317A2/en
Priority to ARP080103355A priority patent/AR068332A1/en
Priority to CA2685540A priority patent/CA2685540C/en
Priority to MX2009012558A priority patent/MX2009012558A/en
Priority to SI200831771A priority patent/SI2170396T1/en
Priority to CL2008002279A priority patent/CL2008002279A1/en
Priority to JP2010518750A priority patent/JP2010535708A/en
Priority to CN200880015923A priority patent/CN101678107A/en
Priority to AU2008285289A priority patent/AU2008285289A1/en
Priority to HUE08788620A priority patent/HUE033195T2/en
Priority to US13/912,375 priority patent/US20140011782A1/en
Priority to HRP20170313TT priority patent/HRP20170313T1/en
Priority to CY20171100278T priority patent/CY1118700T1/en
Ceased legal-status Critical Current

Links

GB0807216A 2007-08-03 2008-04-21 Drug combination for the treatment of duchenne muscular dystrophy Ceased GB0807216D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GB0807216A GB0807216D0 (en) 2008-04-21 2008-04-21 Drug combination for the treatment of duchenne muscular dystrophy
HUE08788620A HUE033195T2 (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
PT87886206T PT2170396T (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
ARP080103355A AR068332A1 (en) 2007-08-03 2008-08-01 DRUG COMBINATIONS FOR THE TREATMENT OF DUCHENNE MUSCLE DYSTROPHY
TW097129385A TW200911237A (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
PE2008001295A PE20090510A1 (en) 2007-08-03 2008-08-01 DRUG COMBINATIONS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
PCT/GB2008/050648 WO2009019504A1 (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
RS20170207A RS55735B1 (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
EP16203981.2A EP3251694A1 (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
EP08788620.6A EP2170396B1 (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
LTEP08788620.6T LT2170396T (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
DK08788620.6T DK2170396T3 (en) 2007-08-03 2008-08-01 PHARMACEUTICAL COMBINATIONS TO TREAT THE MUSCLE DYROPHY OF DUCHENNES
ES08788620.6T ES2617957T3 (en) 2007-08-03 2008-08-01 Pharmacological combinations for the treatment of Duchenne muscular dystrophy
PL08788620T PL2170396T3 (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
BRPI0811317-3A2A BRPI0811317A2 (en) 2007-08-03 2008-08-01 COMBINATION, PHARMACEUTICAL PACKAGING, KIT OR PACKAGING FOR A PATIENT AGENT, AUXILIARY AGENT, COMPOSITE, USES OF AN AUXILIARY AGENT AND COMPOUND, AND PROCESS FOR PRODUCTION OF A COMBINATION
US12/600,242 US8501713B2 (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
CA2685540A CA2685540C (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
MX2009012558A MX2009012558A (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy.
SI200831771A SI2170396T1 (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
CL2008002279A CL2008002279A1 (en) 2007-08-03 2008-08-01 Pharmaceutical combination comprising a heteroarylbicyclic or arylbicyclic compound and an auxiliary agent; Preparation process; and pharmaceutical packaging, useful in the treatment and / or prophylaxis of duchenne muscular dystrophy, becker muscular dystrophy and cachexia.
JP2010518750A JP2010535708A (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of Duchenne muscular dystrophy
CN200880015923A CN101678107A (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of duchenne muscular dystrophy
AU2008285289A AU2008285289A1 (en) 2007-08-03 2008-08-01 Drug combinations for the treatment of Duchenne muscular dystrophy
US13/912,375 US20140011782A1 (en) 2007-08-03 2013-06-07 Drug combinations for the treatment of duchenne muscular dystrophy
HRP20170313TT HRP20170313T1 (en) 2007-08-03 2017-02-24 Drug combinations for the treatment of duchenne muscular dystrophy
CY20171100278T CY1118700T1 (en) 2007-08-03 2017-03-02 MEDICINAL COMBINATIONS FOR THE THERAPEUTIC TREATMENT OF DUCHENNE MUSCLE DYNTROPHY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0807216A GB0807216D0 (en) 2008-04-21 2008-04-21 Drug combination for the treatment of duchenne muscular dystrophy

Publications (1)

Publication Number Publication Date
GB0807216D0 true GB0807216D0 (en) 2008-05-28

Family

ID=39493959

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0807216A Ceased GB0807216D0 (en) 2007-08-03 2008-04-21 Drug combination for the treatment of duchenne muscular dystrophy

Country Status (1)

Country Link
GB (1) GB0807216D0 (en)

Similar Documents

Publication Publication Date Title
LT2170396T (en) Drug combinations for the treatment of duchenne muscular dystrophy
GB0715087D0 (en) Drug combinations for the treatment of duchenne muscular dystrophy
IL228598A0 (en) Treatment of duchenne muscular dystrophy
GB0815369D0 (en) Compounds for treatment of duchenne muscular dystrophy
GB0821307D0 (en) Compounds for treatment of duchenne muscular dystrophy
GB0822981D0 (en) Compounds for treatment of duchenne muscular dystrophy
IL193314A0 (en) Treatment of duchenne muscular dystrophy
GB0715938D0 (en) Method of treatment of duchenne muscular dystrophy
ZA201006827B (en) Carboxamide-heteroaryl derivatives for the treatment of diabetes
ZA200806986B (en) Treatment of duchenne muscular dystrophy
GB0715939D0 (en) Method of treatment of duchenne muscular dystrophy
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
GB0905664D0 (en) Compounds for treatment of duchenne muscular dystrophy
LT2846774T (en) Pharmaceutical composition for the treatment of duchenne muscular dystrophy
GB0905670D0 (en) Compounds for treatment of duchenne muscular dystrophy
HK1139050A1 (en) Medicament for the treatment of pneumonia
GB0807216D0 (en) Drug combination for the treatment of duchenne muscular dystrophy
GB0602767D0 (en) Treatment of muscular dystrophy
GB0715088D0 (en) Drug combinations for the treatment of duchenne muscular dystrophy
GB0905667D0 (en) Compounds for treatment of duchenne muscular dystrophy
EP2641609A4 (en) Therapeutic agent for muscular dystrophy
GB0617739D0 (en) Treatment of duchenne muscular dystrophy
GB0617737D0 (en) Treatment of duchenne muscular dystrophy
GB0623985D0 (en) Treatment of duchenne muscular dystrophy
GB0619281D0 (en) Treatment of duchenne muscular dystrophy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)